{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T18:08:31Z","timestamp":1781114911466,"version":"3.54.1"},"reference-count":43,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2005,10,10]],"date-time":"2005-10-10T00:00:00Z","timestamp":1128902400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2005,10,10]],"date-time":"2005-10-10T00:00:00Z","timestamp":1128902400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,2]]},"DOI":"10.1111\/j.1365-2133.2005.06950.x","type":"journal-article","created":{"date-parts":[[2005,10,10]],"date-time":"2005-10-10T08:19:25Z","timestamp":1128932365000},"page":"345-352","source":"Crossref","is-referenced-by-count":73,"title":["Apolipoprotein E gene polymorphisms are associated with psoriasis but do not determine disease response to acitretin"],"prefix":"10.1093","volume":"154","author":[{"given":"E.","family":"Campalani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.H.","family":"Allen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Fairhurst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.S.","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.O.","family":"Mendonca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.D.","family":"Burden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.E.M.","family":"Griffiths","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.A.","family":"Crook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.N.W.N.","family":"Barker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.H.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2005,10,10]]},"reference":[{"key":"10.1111\/j.1365-2133.2005.06950.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"171","DOI":"10.2340\/0001555574176178","article-title":"Abnormalities of plasma lipoprotein composition and fluidity in psoriasis","volume":"74","author":"Ferretti","year":"1994","journal-title":"Acta Derm Venereol (Stockh)"},{"issue":"Suppl.","key":"10.1111\/j.1365-2133.2005.06950.x-BIB2|cit2","first-page":"38","article-title":"Lipoprotein peroxidation in adult psoriatic patients","volume":"186","author":"Offidani","year":"1994","journal-title":"Acta Derm Venereol (Stockh)"},{"key":"10.1111\/j.1365-2133.2005.06950.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0009-8981(00)00358-2","article-title":"Dislipidemia and oxidative stress in mild and in severe psoriasis as a risk for cardiovascular disease","volume":"303","author":"Rocha-Pereira","year":"2001","journal-title":"Clin Chim Acta"},{"key":"10.1111\/j.1365-2133.2005.06950.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1515\/CCLM.2002.013","article-title":"Serum lipids and apolipoproteins in patients with psoriasis","volume":"40","author":"Uyanik","year":"2002","journal-title":"Clin Chem Lab Med"},{"key":"10.1111\/j.1365-2133.2005.06950.x-BIB5|cit5","first-page":"199","article-title":"High prevalence of cardiovascular diseases and enhanced activity of the renin-angiotensin system in psoriatic patients","volume":"40","author":"Ena","year":"1985","journal-title":"Acta Cardiol"},{"key":"10.1111\/j.1365-2133.2005.06950.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/0190-9622(95)91336-X","article-title":"Disease concomitance in psoriasis","volume":"32","author":"Henseler","year":"1995","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2005.06950.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1159\/000249365","article-title":"Diseases associated with psoriasis in a general population of 159,200 middle-aged, urban, native Swedes","volume":"172","author":"Lindegard","year":"1986","journal-title":"Dermatologica"},{"key":"10.1111\/j.1365-2133.2005.06950.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1023\/B:EJEP.0000020447.59150.f9","article-title":"Increased risk for cardiovascular mortality in psoriasis inpatients but not in outpatients","volume":"19","author":"Mallbris","year":"2004","journal-title":"Eur J Epidemiol"},{"key":"10.1111\/j.1365-2133.2005.06950.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.1365-2133.1978.tb02012.x","article-title":"Psoriasis and occlusive vascular disease","volume":"99","author":"McDonald","year":"1978","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2005.06950.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1126\/science.3283935","article-title":"Apolipoprotein E: cholesterol transport protein with expanding role in cell biology","volume":"240","author":"Mahley","year":"1988","journal-title":"Science"},{"key":"10.1111\/j.1365-2133.2005.06950.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1146\/annurev.genom.1.1.507","article-title":"Apolipoprotein E: far more than a lipid transport protein","volume":"1","author":"Mahley","year":"2000","journal-title":"Annu Rev Genomics Hum Genet"},{"key":"10.1111\/j.1365-2133.2005.06950.x-BIB12|cit12","first-page":"268","article-title":"Role of the apolipoprotein E polymorphism in determining normal plasma lipid and lipoprotein variation","volume":"37","author":"Sing","year":"1985","journal-title":"Am J Hum Genet"},{"key":"10.1111\/j.1365-2133.2005.06950.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1101\/gr.146900","article-title":"Sequence diversity and large-scale typing of SNPs in the human apolipoprotein E gene","volume":"10","author":"Nickerson","year":"2000","journal-title":"Genome Res"},{"key":"10.1111\/j.1365-2133.2005.06950.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1016\/S0022-2275(20)32417-2","article-title":"Pathogenesis of type III hyperlipoproteinemia (dysbetalipoproteinemia). Questions, quandaries, and paradoxes","volume":"40","author":"Mahley","year":"1999","journal-title":"J Lipid Res"},{"key":"10.1111\/j.1365-2133.2005.06950.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0021-9150(95)05681-5","article-title":"Apolipoprotein E polymorphism in middle-aged Belgian men: phenotype distribution and relation to serum lipids and lipoproteins","volume":"120","author":"Braeckman","year":"1996","journal-title":"Atherosclerosis"},{"key":"10.1111\/j.1365-2133.2005.06950.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1177\/000331970305400108","article-title":"Apolipoprotein E polymorphism and atherosclerosis","volume":"54","author":"Kolovou","year":"2003","journal-title":"Angiology"},{"key":"10.1111\/j.1365-2133.2005.06950.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1161\/01.ATV.14.9.1412","article-title":"Impact of apolipoprotein E polymorphism on lipoproteins and risk of myocardial infarction. The ECTIM Study","volume":"14","author":"Luc","year":"1994","journal-title":"Arterioscler Thromb"},{"key":"10.1111\/j.1365-2133.2005.06950.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0021-9150(95)06643-8","article-title":"Apolipoprotein E polymorphism influence on lipids, apolipoproteins and Lp(a) in a Spanish population underexpressing apo E4","volume":"121","author":"Muros","year":"1996","journal-title":"Atherosclerosis"},{"key":"10.1111\/j.1365-2133.2005.06950.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1067\/mlc.2002.129067","article-title":"Differential metabolism of apolipoprotein E isoproteins","volume":"140","author":"Reardon","year":"2002","journal-title":"J Lab Clin Med"},{"key":"10.1111\/j.1365-2133.2005.06950.x-BIB20|cit20","first-page":"79","article-title":"[Immunohistochemical study for the localization of apolipoprotein AI, B100, and E in normal and psoriatic skin.]","volume":"61","author":"Miyauchi","year":"1991","journal-title":"Igaku Kenkyu"},{"key":"10.1111\/j.1365-2133.2005.06950.x-BIB21|cit21","first-page":"224","article-title":"Serum apolipoprotein levels of psoriatic patients with normal serum lipid levels","volume":"12","author":"Xiao","year":"1997","journal-title":"Chin Med Sci J"},{"key":"10.1111\/j.1365-2133.2005.06950.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/sj.tpj.6500067","article-title":"Molecular classification of psoriasis disease-associated genes through pharmacogenomic expression profiling","volume":"1","author":"Oestreicher","year":"2001","journal-title":"Pharmacogenomics J"},{"key":"10.1111\/j.1365-2133.2005.06950.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s004030050229","article-title":"Association of apolipoprotein allele epsilon 2 with psoriasis vulgaris in Japanese population","volume":"289","author":"Furumoto","year":"1997","journal-title":"Arch Dermatol Res"},{"key":"10.1111\/j.1365-2133.2005.06950.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1016\/S0190-9622(99)70359-2","article-title":"Acitretin in psoriasis: an overview of adverse effects","volume":"41","author":"Katz","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2005.06950.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"358","DOI":"10.2165\/00003495-199753030-00003","article-title":"Current use and future potential role of retinoids in dermatology","volume":"53","author":"Orfanos","year":"1997","journal-title":"Drugs"},{"key":"10.1111\/j.1365-2133.2005.06950.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1016\/S0190-9622(99)70360-9","article-title":"Acitretin: optimal dosing strategies","volume":"41","author":"Ling","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2005.06950.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1034\/j.1600-0625.2002.120420.x","article-title":"A Crohn's disease-associated insertion polymorphism (3020insC) in the NOD2 gene is not associated with psoriasis vulgaris, palmo-plantar pustular psoriasis or guttate psoriasis","volume":"12","author":"Young","year":"2003","journal-title":"Exp Dermatol"},{"key":"10.1111\/j.1365-2133.2005.06950.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1093\/hmg\/9.5.725","article-title":"High resolution analysis of haplotype diversity and meiotic crossover in the human TAP2 recombination hotspot","volume":"9","author":"Jeffreys","year":"2000","journal-title":"Hum Mol Genet"},{"key":"10.1111\/j.1365-2133.2005.06950.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1086\/303070","article-title":"Apolipoprotein E variation at the sequence haplotype level: implications for the origin and maintenance of a major human polymorphism","volume":"67","author":"Fullerton","year":"2000","journal-title":"Am J Hum Genet"},{"key":"10.1111\/j.1365-2133.2005.06950.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1086\/342217","article-title":"Contributions of 18 additional DNA sequence variations in the gene encoding apolipoprotein E to explaining variation in quantitative measures of lipid metabolism","volume":"71","author":"Stengard","year":"2002","journal-title":"Am J Hum Genet"},{"key":"10.1111\/j.1365-2133.2005.06950.x-BIB31|cit31","doi-asserted-by":"crossref","first-page":"582","DOI":"10.7326\/0003-4819-136-8-200204160-00007","article-title":"High risk for hyperlipidemia and the metabolic syndrome after an episode of hypertriglyceridemia during 13-cis retinoic acid therapy for acne: a pharmacogenetic study","volume":"136","author":"Rodondi","year":"2002","journal-title":"Ann Intern Med"},{"key":"10.1111\/j.1365-2133.2005.06950.x-BIB32|cit32","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1001\/archderm.104.3.328","article-title":"Psoriasis in Japan","volume":"104","author":"Aoki","year":"1971","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1365-2133.2005.06950.x-BIB33|cit33","doi-asserted-by":"crossref","first-page":"R43","DOI":"10.1093\/hmg\/ddh094","article-title":"The genetics of psoriasis, psoriatic arthritis and atopic dermatitis","volume":"13","author":"Bowcock","year":"2004","journal-title":"Hum Mol Genet"},{"key":"10.1111\/j.1365-2133.2005.06950.x-BIB34|cit34","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1001\/archderm.137.11.1447","article-title":"The genetics of psoriasis 2001: the odyssey continues","volume":"137","author":"Elder","year":"2001","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1365-2133.2005.06950.x-BIB35|cit35","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/BF00376613","article-title":"Study of HLA class I, class II and complement genes (C2, C4A, C4B and BF) in Japanese psoriatics and analysis of a newly-found high-risk haplotype by pulsed field gel electrophoresis","volume":"283","author":"Nakagawa","year":"1991","journal-title":"Arch Dermatol Res"},{"key":"10.1111\/j.1365-2133.2005.06950.x-BIB36|cit36","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1111\/j.1365-2133.1994.tb03411.x","article-title":"Serum lipid and apolipoprotein levels in patients with psoriasis","volume":"130","author":"Seishima","year":"1994","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2005.06950.x-BIB37|cit37","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/1522-2683(200202)23:2<161::AID-ELPS161>3.0.CO;2-P","article-title":"Lipoproteins modulate growth and differentiation of cultured human epidermal keratinocytes","volume":"23","author":"Furumoto","year":"2002","journal-title":"Electrophoresis"},{"key":"10.1111\/j.1365-2133.2005.06950.x-BIB38|cit38","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1046\/j.1365-2362.2000.00715.x","article-title":"Apolipoprotein E-deficient mice have an impaired immune response to Klebsiella pneumoniae","volume":"30","author":"De Bont","year":"2000","journal-title":"Eur J Clin Invest"},{"key":"10.1111\/j.1365-2133.2005.06950.x-BIB39|cit39","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1016\/S0022-2275(20)32160-X","article-title":"Apolipoprotein E-deficient mice have impaired innate immune responses to Listeria monocytogenes in vivo","volume":"39","author":"Roselaar","year":"1998","journal-title":"J Lipid Res"},{"key":"10.1111\/j.1365-2133.2005.06950.x-BIB40|cit40","first-page":"447","article-title":"Regulation of lymphocyte proliferation by cholesterol: the role of endogenous sterol metabolism and low density lipoprotein receptors","volume":"9","author":"Cuthbert","year":"1987","journal-title":"Int J Tissue React"},{"key":"10.1111\/j.1365-2133.2005.06950.x-BIB41|cit41","doi-asserted-by":"crossref","first-page":"4539","DOI":"10.1073\/pnas.81.14.4539","article-title":"Modulation of human lymphocyte responses by low density lipoproteins (LDL): enhancement but not immunosuppression is mediated by LDL receptors","volume":"81","author":"Cuthbert","year":"1984","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/j.1365-2133.2005.06950.x-BIB42|cit42","doi-asserted-by":"crossref","first-page":"11775","DOI":"10.1016\/S0021-9258(19)70201-4","article-title":"Immunoregulatory plasma lipoproteins. Role of apoprotein E and apoprotein B","volume":"255","author":"Hui","year":"1980","journal-title":"J Biol Chem"},{"key":"10.1111\/j.1365-2133.2005.06950.x-BIB43|cit43","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1161\/hc4101.097518","article-title":"Risk factors for cardiovascular disease in systemic lupus erythematosus","volume":"104","author":"Svenungsson","year":"2001","journal-title":"Circulation"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2133.2005.06950.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2133.2005.06950.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2133.2005.06950.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,30]],"date-time":"2024-01-30T21:15:02Z","timestamp":1706649302000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/154\/2\/345\/6637075"}},"subtitle":["ApoE gene polymorphisms, psoriasis and acitretin"],"short-title":[],"issued":{"date-parts":[[2005,10,10]]},"references-count":43,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,2]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2133.2005.06950.x","archive":["Portico"],"relation":{},"ISSN":["0007-0963"],"issn-type":[{"value":"0007-0963","type":"print"}],"subject":[],"published":{"date-parts":[[2005,10,10]]}}}